Cross-sectional studies reported that hepatitis B core gene mutations are associated with active liver disease and responsiveness to interferon therapy. In view of the heterogeneity in published sequences, it is not possible to tell whether the differences in sequences observed were true mutations t
The immune response in chronic hepatitis B virus infection: The “Core” of the problem?
✍ Scribed by James R. Baker Jr.
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 430 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
✦ Synopsis
Individuals with chronic hepatitis B virus (HBV)
📜 SIMILAR VOLUMES
IFN-a and lamivudine, were treated with 16 weeks of 10 megaunits PBMC, peripheral blood mononuclear cell; SI, stimulation index; ALT, alanine transami-of recombinant IFN-a 2b (Intron-A; Schering-Plough, Welwyn Garnase. den City, England) subcutaneously three times a week and 100 mg From the Institu
Chronic hepatitis B virus (HBV) infection is characterized by a weak immune response to HBV. Regulatory T cells (T(reg)) can suppress the function of effector T cells and may thus be key players in this impaired immune response. Changes in the functionality or number of T(reg) could explain the decr
Recent advances in our understanding of the replicative mechanism of HBV, and the development of potent nucleoside analogues as clinically effective inhibitors of the HIV reverse transcriptase or herpesvirus polymerases has opened a new era in the treatment of chronic HBV infection. Single agent the
Chronic hepatitis B virus (HBV) infection has a complicated course. Three phases are identified: an immune tolerant phase with high HBV DNA and normal alanine aminotransferase (ALT) levels associated with minimal liver disease; an immune active phase with high HBV DNA and elevated ALT levels with ac
Immunoglobulin GM and KM allotypes-genetic markers of ␥ and chains, respectively-are associated with immune responsiveness to several infectious pathogens and with survival in certain viral epidemics. We hypothesized that GM and KM allotypes affect the outcome of hepatitis C virus (HCV) infection. T